Sculptor Capital LP - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Sculptor Capital LP ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2016$6,702,000
-45.0%
148,200
-50.0%
0.04%
-38.7%
Q1 2016$12,186,000
-50.8%
296,648
-54.3%
0.06%
-54.1%
Q4 2015$24,756,000
-56.6%
648,922
-62.6%
0.14%
-31.8%
Q3 2015$57,069,000
+316.6%
1,737,259
+829.5%
0.20%
+435.1%
Q4 2014$13,698,000
-2.9%
186,900
-4.9%
0.04%
-9.8%
Q3 2014$14,103,000
-1.4%
196,500
-0.7%
0.04%
-4.7%
Q2 2014$14,301,000
-3.8%
197,800
-2.1%
0.04%
-12.2%
Q1 2014$14,860,000
-65.8%
201,953
-67.7%
0.05%
-56.2%
Q4 2013$43,493,000
-13.1%
625,349
-17.9%
0.11%
-21.1%
Q3 2013$50,043,000
-6.0%
761,800
-0.8%
0.14%
-15.0%
Q2 2013$53,213,000768,2000.17%
Other shareholders
BAXTER INTL INC shareholders Q3 2015
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders